Retatrutide is currently in Phase 3 clinical trials and is not yet approved by Health Canada or the FDA for obesity treatment
She adds that the same lens is applied across mediabe it print, TV, digital, OOH, PR, social and influencer content
According to a press release from Lemme, GLP-1 Daily is a plant-based GLP-1 supplement that is designed to boost GLP-1 hormone levels, reduce hunger and cravings, and support healthy weight management. In the release, Kardashians doctor and Lemme medical advisor Kathleen Valenton, MD, says, So many of my patients are looking for natural solutions for GLP-1 support which is why Im so proud of this breakthrough formulation. Speaking to Vogue , Valenton positions the supplement as a natural alternative to GLP-1 agonist medications like Ozempic, but without side effects like nausea and other gastrointestinal complaints, which are common among injectable GLP-1 agonist users
Shu Q, Chen L, Wu S, Li J, Liu J, Xiao L, et al
These medications rely on prolonged use to maintain results, leaving many individuals grappling with dependency, side effects, or diminishing effectiveness over time
25 Jul 2026 Compound overview A laboratory-focused primer on Retatrutide literature pointers and quality checks without human-use claims